Lataa...
A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC
The intracellular distribution of a drug can cause significant variability in both activity and selectivity. Herein, we investigate the mechanism by which the anti-cancer agents, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) and the clinically trialed, di-2-pyridylketone 4-cyclohexyl-...
Tallennettuna:
| Julkaisussa: | Cell Death Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5261000/ https://ncbi.nlm.nih.gov/pubmed/27906178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2016.381 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|